JPS62193638A - Granular agent - Google Patents
Granular agentInfo
- Publication number
- JPS62193638A JPS62193638A JP61036442A JP3644286A JPS62193638A JP S62193638 A JPS62193638 A JP S62193638A JP 61036442 A JP61036442 A JP 61036442A JP 3644286 A JP3644286 A JP 3644286A JP S62193638 A JPS62193638 A JP S62193638A
- Authority
- JP
- Japan
- Prior art keywords
- granules
- chitosan
- powder
- granular agent
- acid salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008187 granular material Substances 0.000 claims abstract description 69
- 229920001661 Chitosan Polymers 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 22
- -1 inorganic acid salt Chemical class 0.000 claims abstract description 14
- 239000011230 binding agent Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 7
- 229940034610 toothpaste Drugs 0.000 claims description 7
- 239000000606 toothpaste Substances 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 13
- 239000002245 particle Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 150000007522 mineralic acids Chemical class 0.000 abstract description 5
- 238000004040 coloring Methods 0.000 abstract description 4
- 150000007524 organic acids Chemical class 0.000 abstract description 4
- 229920002101 Chitin Polymers 0.000 abstract description 3
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 abstract 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 abstract 1
- 229940043256 calcium pyrophosphate Drugs 0.000 abstract 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000000551 dentifrice Substances 0.000 description 12
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 239000000049 pigment Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 239000003232 water-soluble binding agent Substances 0.000 description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 230000006196 deacetylation Effects 0.000 description 4
- 238000003381 deacetylation reaction Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 229910021536 Zeolite Inorganic materials 0.000 description 3
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 3
- 239000001511 capsicum annuum Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 235000013799 ultramarine blue Nutrition 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 208000006558 Dental Calculus Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940083982 sodium phytate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- NBOCQTNZUPTTEI-UHFFFAOYSA-N 4-[4-(hydrazinesulfonyl)phenoxy]benzenesulfonohydrazide Chemical compound C1=CC(S(=O)(=O)NN)=CC=C1OC1=CC=C(S(=O)(=O)NN)C=C1 NBOCQTNZUPTTEI-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005714 Chitosan hydrochloride Substances 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical class O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Glanulating (AREA)
- Formation And Processing Of Food Products (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は顆粒剤に関する。さらに詳しくは、水の存在下
にあっても顆粒剤を構成する粉体粒子の集結力が低下し
ない顆粒剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to granules. More specifically, the present invention relates to a granule in which the cohesion of powder particles constituting the granule does not decrease even in the presence of water.
顆粒という形態は、薬品や食品の分野等でしばしば使用
されるものである。場合によっては、水が存在していて
も顆粒がその形状を保持することが要求されることがあ
る。たとえば、歯磨剤中に配合される顆粒剤がそれに該
当する。顆粒剤を歯磨剤中に配合する目的としては、着
色用粉末を顆粒剤とすることによって歯磨剤の審美的効
果を向上させること、あるいは種々の薬効成分を歯磨剤
中に配合する場合これらの成分が研磨材等の微粒子に強
く多量に吸着されるのを防止するため等が挙げられる。The granule form is often used in the pharmaceutical and food fields. In some cases, it may be required that the granules retain their shape even in the presence of water. For example, granules incorporated into dentifrices fall under this category. The purpose of incorporating granules into dentifrices is to improve the aesthetic effect of dentifrices by turning coloring powder into granules, or to incorporate various medicinal ingredients into dentifrices. For example, the purpose is to prevent the particles from being strongly adsorbed in large quantities by fine particles such as abrasives.
一方、顆粒剤は通常、次のような工程で製造される。On the other hand, granules are usually manufactured through the following steps.
粉体の混合→混練→造粒→乾粒→整粒
すなわち、種々の有効成分や賦形剤、着色剤等の粉体を
結合剤を含む溶液中で混練して顆粒剤とするのである。Powder mixing → kneading → granulation → dry granulation → granulation In other words, powders of various active ingredients, excipients, colorants, etc. are kneaded in a solution containing a binder to form granules.
ここに使用される結合剤には、水溶性のものと水不溶性
のものの2種類がある。水溶性のものとしては、デンプ
ン、ゼラチン、アラビアゴム、メチルセルロース、カル
ボキシメチルセルロースナトリウム、ヒドロキシエチル
セルロース、ポリビニルピロリドン等が例示される。ま
た、水不溶性のものは、有機溶媒に溶解して使用される
が、それらには、エチルセルロース、アセチルセルロー
ス等がある。There are two types of binders used here: water-soluble and water-insoluble. Examples of water-soluble materials include starch, gelatin, gum arabic, methylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, and polyvinylpyrrolidone. Further, water-insoluble ones are used after being dissolved in an organic solvent, and examples thereof include ethyl cellulose and acetyl cellulose.
水溶性の結合剤を用いて作られた顆粒剤は、それを水が
存在する環境、たとえば歯磨剤生地中に配合すると、水
分により顆粒を構成する粉体の集結性が低下し、その形
状が崩壊してしまうという問題があった。When granules made using a water-soluble binder are blended into an environment where water is present, such as in toothpaste dough, the moisture reduces the cohesiveness of the powder that makes up the granules, causing their shape to change. The problem was that it would collapse.
これに対し、水不溶性の結合剤を使用すると、前述のよ
うな集結性の低下の問題はないものの、顆粒剤の製造に
有機溶媒を使用せねばならず、人体への悪影響や火災等
の事故が懸念されることになる。On the other hand, if a water-insoluble binder is used, although there is no problem of reduced cohesiveness as mentioned above, it requires the use of organic solvents in the production of granules, which can cause adverse effects on the human body and accidents such as fire. is a concern.
−F記の問題点を解決するだめ、本発明者らは水溶性の
結合剤を含有していても水が存在する環境下でその形状
が安定に保持される顆粒剤を得るべく、鋭意研究の結果
、本発明を完成させた。- In order to solve the problem described in F, the present inventors conducted extensive research in order to obtain granules that stably maintain their shape in an environment where water exists even though they contain a water-soluble binder. As a result, the present invention was completed.
すなわち、本発明はキトサンの無機酸蔗塩又は/及び有
機酸塩を粉体の結合剤として配合したこと全特徴とする
顆粒剤を提供するものである。That is, the present invention provides a granule having the following characteristics: an inorganic acid sulfate salt and/or an organic acid salt of chitosan is blended as a powder binder.
本発明で顆粒剤とは、粉体粒子どうしの集合体であり、
肉眼でその存在が確認できる程度の太きさのものを意味
する。In the present invention, granules are aggregates of powder particles,
It means something that is so thick that its existence can be confirmed with the naked eye.
本発明顆粒剤に配合されるキトサンの無機酸塩又は有機
酸塩(以下、単にキトサン塩という)は、キチンの脱ア
セチル化物(キトサン)の塩である。The inorganic or organic acid salt of chitosan (hereinafter simply referred to as chitosan salt) blended into the granules of the present invention is a salt of deacetylated chitin (chitosan).
ここでキチンは、カニ、エビ、昆虫などの甲殻やキノコ
やカビの細胞壁に存在するN−アセテルーD−グルコサ
ミンの重合体である。Here, chitin is a polymer of N-acetel-D-glucosamine that exists in the shells of crabs, shrimp, insects, etc., and in the cell walls of mushrooms and molds.
キトサンは、脱アセチル化度が^い程、分子内にアミノ
基が多く、逆にアセトアミド基が少なくなる。本発明で
は、無機酸又は有機酸の希薄溶液に溶解し得る程度に脱
アセチル化したものであれば使用できるが、脱アセチル
化度が60%以上のものが好適である。The higher the degree of deacetylation of chitosan, the more amino groups there are in the molecule, and the fewer acetamido groups there are. In the present invention, any material that has been deacetylated to the extent that it can be dissolved in a dilute solution of an inorganic or organic acid can be used, but those with a degree of deacetylation of 60% or more are preferred.
キトサン塩を調製するに際し用いる無機酸としては、塩
酸、硫酸、リン酸等が例示でき、有機酸としては、酢酸
、クエン酸、リンゴ酸、7マル酸、マレイン酸、コハク
酸、乳酸等があげられる。Examples of inorganic acids used in preparing chitosan salt include hydrochloric acid, sulfuric acid, phosphoric acid, etc., and examples of organic acids include acetic acid, citric acid, malic acid, hexamaric acid, maleic acid, succinic acid, lactic acid, etc. It will be done.
本発明顆粒剤に配合される粉体粒子は、顆粒剤が水の存
在下で製造されるため、水や酸に不溶若しくは難溶のも
のであることが必要である。具体例としては、第2リン
酸カルシウム、不溶性メタリン酸ナトリウム、ビロリン
酸カルシウム、アルミナ、水酸化アルミニウム、炭酸カ
ルシウム、ゼオライト、無水ケイ酸、含水ケイ酸等の主
に歯磨剤の研磨剤として使用される粉体;さらに、乳糖
、結晶性セルロース、デンプン、タルク、ナイロン、ポ
リスチレン等の主として顆粒剤の賦形剤として使用され
る粉体が挙げられる。Since the granules are manufactured in the presence of water, the powder particles added to the granules of the present invention need to be insoluble or sparingly soluble in water and acids. Specific examples include powders mainly used as abrasives in toothpaste such as dicalcium phosphate, insoluble sodium metaphosphate, calcium birophosphate, alumina, aluminum hydroxide, calcium carbonate, zeolite, anhydrous silicic acid, and hydrated silicic acid. Further examples include powders mainly used as excipients for granules, such as lactose, crystalline cellulose, starch, talc, nylon, and polystyrene.
本発明の顆粒剤は、上記の水に不溶若しくは難溶の粉体
をベースにし、キトサン塩を結合剤として構成されるが
、これらの成分以外に目的に応じて種々の物質を顆粒剤
の成分として取り入れることができる。例えば、着色す
るための各種無機あるいは有機(天然と合成の)顔料、
さらに具体的には、群青やベンガラ、酸化チタン等の無
機顔料;パプリカ色素や紫根などの食品用天然色素;赤
色3号や青色1号などの医薬品に使用可能タール系色素
およびそのレーキ類等である。The granules of the present invention are composed of the above water-insoluble or sparingly soluble powder as a base and chitosan salt as a binder, but in addition to these ingredients, various substances may be added to the granules depending on the purpose. It can be incorporated as For example, various inorganic or organic (natural and synthetic) pigments for coloring;
More specifically, inorganic pigments such as ultramarine blue, red iron oxide, and titanium oxide; natural food pigments such as paprika pigment and purple root; tar-based pigments that can be used in pharmaceuticals such as Red No. 3 and Blue No. 1, and their lakes; be.
また、各種薬用成分、たとえば、塩酸クロルヘキシジン
、グルコン酸クロルヘキシジン、ε−アミノカプロン酸
、トラネキサム酸、ジヒドロコレスタノール、アラント
イン、アラントインクロルヒドロキシルアルミニウム、
モノフルオルリン酸ナトリウム、フン化スズ、フィチン
酸、デキストラナーゼ、ムタナーゼ、グロテアーゼ、リ
ゾチーム、塩化ナトリウム、セチルピリジニウムクロリ
ド、ビタミンE1 ビタミンEのエステル、ビタミンC
等も顆粒剤の成分に取り入れることができる。In addition, various medicinal ingredients such as chlorhexidine hydrochloride, chlorhexidine gluconate, ε-aminocaproic acid, tranexamic acid, dihydrocholestanol, allantoin, allantoin chlorhydroxylaluminum,
Sodium monofluorophosphate, tin fluoride, phytic acid, dextranase, mutanase, grotease, lysozyme, sodium chloride, cetylpyridinium chloride, vitamin E1, ester of vitamin E, vitamin C
etc. can also be incorporated into the ingredients of granules.
これらの顔料や薬効成分が水に不溶あるいは難溶であれ
ば、これらを本発明の顆粒剤のベースにすることもでき
る。If these pigments and medicinal ingredients are insoluble or sparingly soluble in water, they can also be used as the base of the granules of the present invention.
本発明の顆粒剤は、例えば次の方法により製造すること
ができる。すなわち、キトサンを無機酸及び/又は有機
酸の水溶液に溶解し、この溶液中に顆粒剤の構成成分と
なる各種粉体等を加えて混練する。次いで得られた混線
物を造粒、乾燥することにより製造される。造粒法とし
ては、押出し造粒法や噴霧造粒法等が利用できる。The granules of the present invention can be produced, for example, by the following method. That is, chitosan is dissolved in an aqueous solution of an inorganic acid and/or an organic acid, and various powders, etc. that will be constituent components of the granules are added to this solution and kneaded. Next, the obtained mixed wire material is granulated and dried to produce the product. As the granulation method, extrusion granulation method, spray granulation method, etc. can be used.
本発明顆粒剤中へのキトサン塩の配合量は、各種用途に
応じて決定することができる。すなわち、キトサン塩の
配合量が多くなるにつれて、顆粒剤の崩壊強度も大きく
なるので、顆粒剤の用途によって好ましい崩壊強度とな
るようにキトサン塩の量を調整することができる。まだ
、キトサン塩に加えて、前記の各種水溶性結合剤を併用
することによっても顆粒剤の崩壊強度を調整することが
できる。例えば、本発明の顆粒剤が歯磨剤に配合するた
めのものである場合には、当該顆粒剤の崩壊強度は、顆
粒剤が歯磨剤に配合されるときはその形状が保持されて
おり、歯を磨く行為によって容易にそれが崩壊する程度
のものが好ましい。そのためのキトサン塩の配合量は、
顆粒剤の構成成分の種類や量によって異なるが、0.5
〜20重量%の範囲である。例えば平均粒径が20ミク
ロン以下の粉体を構成成分とし、脱アセチル化度60%
以上のキトサンからなるキトサン塩を用いた顆粒剤の場
合、キトサン塩の配合量は1〜5重4%であることが好
ましい。また、顆粒剤の平均直径は150〜1,000
ミクロンが適当である。The amount of chitosan salt to be incorporated into the granules of the present invention can be determined depending on various uses. That is, as the amount of chitosan salt added increases, the disintegration strength of the granules also increases, so the amount of chitosan salt can be adjusted to provide a preferable disintegration strength depending on the use of the granules. In addition to the chitosan salt, the disintegration strength of the granules can also be adjusted by using the various water-soluble binders described above. For example, when the granules of the present invention are to be incorporated into a dentifrice, the disintegration strength of the granules is such that when the granules are incorporated into the dentifrice, their shape is maintained and It is preferable that it be easily disintegrated by the act of polishing. The amount of chitosan salt to be added for this purpose is
It varies depending on the type and amount of the constituent components of the granules, but the amount is 0.5
-20% by weight. For example, the constituent components are powders with an average particle size of 20 microns or less, and the degree of deacetylation is 60%.
In the case of granules using chitosan salt made of chitosan as described above, the amount of chitosan salt blended is preferably 1 to 5% by weight and 4%. In addition, the average diameter of the granules is 150 to 1,000.
Micron is appropriate.
キトサン塩を結合剤とする本発明の顆粒剤は、その製造
工程において水を溶媒として使用するだめ、有機溶媒を
使用する場合に必要な火災予防などの施設が不要である
という利点を有する。また、通常の水溶性結合剤を使用
した顆粒剤のように水の存在下、たとえば歯磨剤中の水
分によってその形状が崩壊することがない。従って、歯
磨剤中において着色用粉末や薬効成分を顆粒中に保持せ
しめ、その審美効果、薬効の喪失を防止することができ
る。The granules of the present invention using chitosan salt as a binder have the advantage that since water is used as a solvent in the manufacturing process, there is no need for facilities such as fire prevention, which are required when organic solvents are used. Furthermore, unlike granules using ordinary water-soluble binders, their shape does not collapse in the presence of water, for example, due to moisture in toothpaste. Therefore, it is possible to retain the coloring powder and medicinal ingredients in the granules in the dentifrice, thereby preventing the aesthetic effect and medicinal effect from being lost.
次に実施例を挙げて本発明を説明する。 Next, the present invention will be explained with reference to Examples.
実施例1
種々の結合剤を用いて顆粒剤を製造し、これを水中で機
械的に攪拌したときの顆粒形状保持力について試験した
。Example 1 Granules were produced using various binders and tested for granule shape retention when mechanically stirred in water.
(1)材料
■粉体
第2リン酸カルシウム・2水和塩(東洋ス■結合剤
・キトサン酢酸塩〔キトサン(片倉チンヵリン■製、脱
アセチル度80%以上)を1%酢酸水溶液に溶解して調
製〕
・カルボキシメチルセルロースナトリウム〔第一工業製
薬■製、商品名セロゲンF−8EXを精製水に溶解して
使用: CMC−Naと略す〕・ヒドロキシエチルセル
ロース〔ダイセル化学工業■製、商品名f(EC−ユニ
セルQP−4400Hを精製水に溶解して使用、HEC
と略す〕
(2)顆粒剤の製法
第2リン酸カルシウム・2水和塩100重量部に対し、
結合剤が3,5重量部になる様に結合剤の溶液を加えて
十分に混練し、これを20メツシユの篩を通して押出し
造粒後、90℃で3時間加熱乾燥して顆粒剤を製造した
。その後、粒子径を選別し、25メツシユの篩を通過し
3゜メツシュの篩に捕捉されたものを以下の実験に使用
した。(1) Materials ■ Powdered dicalcium phosphate dihydrate salt (Toyosu ■ Binder / Chitosan acetate [Prepared by dissolving chitosan (manufactured by Katakura Chinkarin ■, deacetylation degree 80% or more) in 1% acetic acid aqueous solution ] ・Carboxymethylcellulose sodium [manufactured by Daiichi Kogyo Seiyaku ■, trade name Celogen F-8EX dissolved in purified water: abbreviated as CMC-Na] ・Hydroxyethyl cellulose [manufactured by Daicel Chemical Industries ■, trade name f (EC- Use Unicell QP-4400H dissolved in purified water, HEC
(2) Manufacturing method of granules For 100 parts by weight of dicalcium phosphate dihydrate,
A binder solution was added so that the binder amount was 3.5 parts by weight, and the mixture was thoroughly kneaded, extruded through a 20-mesh sieve, granulated, and heated and dried at 90°C for 3 hours to produce granules. . Thereafter, the particle size was selected, and the particles that passed through a 25 mesh sieve and were captured on a 3° mesh sieve were used in the following experiment.
(3)顆粒剤の形状保持力評価方法
水中における顆粒剤の形状保持力を評価するために第1
0改正日本薬局方に規定された崩壊試験機(富山産業株
式会社製)を用いた。まず顆粒剤50■を補助筒に秤り
取り、これを50mMクエン酸リン酸緩衝液(pH5,
0〜s、o 。(3) Evaluation method for shape retention of granules In order to evaluate the shape retention of granules in water,
A disintegration tester (manufactured by Toyama Sangyo Co., Ltd.) specified in the Japanese Pharmacopoeia 0 revised edition was used. First, weigh out 50 μg of granules into an auxiliary tube, add this to 50 mM citrate phosphate buffer (pH 5,
0~s, o.
37℃)に浸漬し、1分間に45ストロークの頻度で上
下運動させた。20分間作動した後、補助筒中に、残存
する顆粒の量を観察して以下の基準により形状保持力を
評価した。37° C.) and moved up and down at a frequency of 45 strokes per minute. After operating for 20 minutes, the amount of granules remaining in the auxiliary tube was observed and the shape retention was evaluated according to the following criteria.
評価基準:
○: 良 好 (補助筒に顆粒が大部分残存)Δ:
不 良 (補助筒に顆粒が2程度残存)×: 極
めて不良(補助筒に顆粒がほとんど残存せず)結果を表
1に示す。その結果、水溶性結合剤であるC MC−N
aやHECを使用した顆粒剤は、形状保持力が劣ってい
るが、キトサン酢酸塩を使用した本発明顆粒剤は、優れ
た形状保持力を有している。Evaluation criteria: ○: Good (Most of the granules remain in the auxiliary cylinder) Δ:
Poor (about 2 granules remained in the auxiliary cylinder) ×: Extremely poor (almost no granules remained in the auxiliary cylinder) The results are shown in Table 1. As a result, the water-soluble binder C MC-N
Granules using a or HEC have poor shape retention, but the granules of the present invention using chitosan acetate have excellent shape retention.
さらにキトサンの塩酸塩、リン酸塩、クエン酸塩及びコ
ハク酸塩を用いて同様の試験を行ったところ、はぼ同一
の結果が得られた。Furthermore, when similar tests were conducted using chitosan hydrochloride, phosphate, citrate, and succinate, almost identical results were obtained.
表 1
実施例2
4A型ゼオライト粉末(花王■製、平均粒径2ミクロン
)100重量部と、着色剤として群青(和光紬薬■製)
1重畦部をよく混合した。これにキトサン(実施例1と
同じ)3重量部を1パーセント酢酸水溶液に溶解して加
え、これらを混練した。この粘土状の混合物を20メツ
シユの篩で押出し造粒し、90℃で3時間乾燥して顆粒
剤とした。さらに20メツシユの篩を通して大粒径のも
のを除去し、また80メツシユの篩で粉末を除いて青色
の顆粒剤を得た。この顆粒剤を歯磨剤に配合すれば、ゼ
オライトの歯石予防効果と群青の審美性を得ることがで
きる。Table 1 Example 2 100 parts by weight of 4A type zeolite powder (manufactured by Kao ■, average particle size 2 microns) and ultramarine blue (manufactured by Wako Tsumugi Pharmaceutical ■) as a coloring agent.
The single layer ridge was thoroughly mixed. To this was added 3 parts by weight of chitosan (same as in Example 1) dissolved in a 1% acetic acid aqueous solution, and these were kneaded. This clay-like mixture was granulated by extrusion through a 20-mesh sieve, and dried at 90° C. for 3 hours to obtain granules. Further, large particles were removed through a 20-mesh sieve, and powder was removed through an 80-mesh sieve to obtain blue granules. By incorporating this granule into a dentifrice, it is possible to obtain the tartar prevention effect of zeolite and the esthetics of ultramarine blue.
実施例3
アラントインクロルヒドロキシアルミニウム(用便ファ
インケミカル(掬製)50重量部に無水ケイ酸10重量
部とパプリカ色素(水和物産■製)1重量部を混合し、
これにキトサン(実施例1と同じ)2電歇部を1パーセ
ント酢酸水溶液に溶解して加え、混練した。この粘土状
の混合物を20メンシユの篩で押出し造粒し、90℃3
時間加熱乾燥して顆粒剤とし、さらに20メツシユの篩
を通して大粒径のものを除去し、また80メツシユの篩
で粉末を除いて橙赤色の顆粒剤を得た。この顆粒剤を歯
磨剤に配合すればアラントインクロルヒドロキシアルミ
ニウムの歯肉炎予防効果とパプリカ色素の審美性を得る
ことができる。Example 3 10 parts by weight of silicic anhydride and 1 part by weight of paprika pigment (manufactured by Hydrate Bussan ■) were mixed with 50 parts by weight of allantoin chlorhydroxyaluminum (Yobin Fine Chemicals (manufactured by Kiki),
Two parts of chitosan (same as in Example 1) dissolved in a 1% acetic acid aqueous solution was added to this and kneaded. This clay-like mixture was extruded through a 20-mesh sieve and granulated at 90°C.
The mixture was heated and dried for a period of time to form granules, which were then passed through a 20-mesh sieve to remove large particles, and then through an 80-mesh sieve to remove powder to obtain orange-red granules. By incorporating this granule into a dentifrice, it is possible to obtain the gingivitis preventive effect of allantoin chlorhydroxyaluminum and the aesthetic properties of paprika pigment.
実施例4
フィチン酸ナトリウム(シグマ社製)1重量部に乳糖5
0重量部を混合し、これにキトサン(実施例1と同じ)
2重量部を1パーセント酢酸水溶液に溶解して加え、混
練した。この粘土状の混合物を20メツシユの篩で押出
し造粒し、90℃3時間加熱乾燥して顆粒剤を得だ。さ
らに20メツシユの篩を通して大粒径のものを除去し、
また80メツシユの篩で粉末を除いて白色の顆粒剤を得
た。Example 4 5 parts of lactose in 1 part by weight of sodium phytate (manufactured by Sigma)
0 parts by weight and chitosan (same as Example 1)
Two parts by weight were dissolved in a 1% acetic acid aqueous solution and added, followed by kneading. This clay-like mixture was granulated by extrusion through a 20 mesh sieve, and dried by heating at 90°C for 3 hours to obtain granules. Furthermore, large particles are removed through a 20-mesh sieve.
Further, powder was removed using an 80-mesh sieve to obtain white granules.
この顆粒剤を歯磨剤に配合すれば、フィチン酸ナトリウ
ムの歯石予防効果を得ることができる。If this granule is added to a dentifrice, the tartar preventive effect of sodium phytate can be obtained.
参考例1
実施例2〜4で得られた顆粒剤を下記に示した歯磨剤生
地1および2の98重量部に2重量部添加し、室温にて
10分間脱気攪拌して顆粒剤配合歯磨剤を製造した。こ
の時、実施例2〜4の顆粒剤はいずれも形状が良好に保
持されていた。また、この顆粒剤配合歯磨剤をラミネー
トチューブに充填し、40°Cにて30日間保存する加
速試験を行ったところ、保存後にも顆粒剤の形状は完全
に保持されていた。Reference Example 1 2 parts by weight of the granules obtained in Examples 2 to 4 were added to 98 parts by weight of dentifrice materials 1 and 2 shown below, and the mixture was deaerated and stirred at room temperature for 10 minutes to produce a granule-containing toothpaste. The drug was manufactured. At this time, the granules of Examples 2 to 4 all maintained their shapes well. Further, when an accelerated test was carried out in which the dentifrice containing granules was filled into a laminated tube and stored at 40°C for 30 days, the shape of the granules was completely retained even after storage.
く歯磨剤生地1〉
第2リン酸カルシウム・2水和塩 40重量係グ
リセリン 1070%ソルビ
トール 14カルボキシメチルセル
ロースナトリウム 2ラウリル硫酸ナトリウム
1.5サツカリンナトリウム
0.2香 料
0.8精製水 適量
計100重量%
〈歯磨剤生地2〉
無水ケイ酸 20重竜チグ
リセリン 3070%ンルビト
ール 30カルボキシメチルセルロ
ースナトリウム 2ラウリル硫酸ナトリウム
1.5サツカリンナトリウム
0.1香 料
0.7精製水 適量
計100重i%
以上Toothpaste fabric 1> Dibasic calcium phosphate dihydrate salt 40 Glycerin by weight 1070% sorbitol 14 Sodium carboxymethyl cellulose 2 Sodium lauryl sulfate
1.5 Satucalin Sodium
0.2 fragrance
0.8 Purified water Appropriate amount 100% by weight <Toothpaste dough 2> Silicic anhydride 20 Heavy tiglycerin 3070% Nlubitol 30 Sodium carboxymethyl cellulose 2 Sodium lauryl sulfate
1.5 Satucalin Sodium
0.1 fragrance
0.7 Purified water appropriate amount 100% by weight or more
Claims (1)
合剤として配合したことを特徴とする顆粒剤。 2、顆粒剤が歯磨配合用である特許請求の範囲第1項記
載の顆粒剤。[Scope of Claims] 1. A granule comprising an inorganic acid salt and/or an organic acid salt of chitosan as a binder for powder. 2. The granule according to claim 1, which is for use in toothpaste formulation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61036442A JPS62193638A (en) | 1986-02-20 | 1986-02-20 | Granular agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61036442A JPS62193638A (en) | 1986-02-20 | 1986-02-20 | Granular agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62193638A true JPS62193638A (en) | 1987-08-25 |
Family
ID=12469922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61036442A Pending JPS62193638A (en) | 1986-02-20 | 1986-02-20 | Granular agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62193638A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102274A (en) * | 2007-10-24 | 2009-05-14 | Kao Corp | Method for producing dentifrice granule containing non-cationic germicide |
JP2009242241A (en) * | 2007-11-21 | 2009-10-22 | Kao Corp | Dentifrice |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50123815A (en) * | 1974-02-11 | 1975-09-29 | ||
JPS5348190A (en) * | 1976-10-13 | 1978-05-01 | Kobe Steel Ltd | Servo control system |
JPS56136287A (en) * | 1980-03-26 | 1981-10-24 | Nec Corp | Electron beam welding machine in air |
JPS59101416A (en) * | 1982-11-30 | 1984-06-12 | Lion Corp | Oral cavity composition |
JPS59152312A (en) * | 1983-02-18 | 1984-08-31 | Lion Corp | Oral cavity composition |
-
1986
- 1986-02-20 JP JP61036442A patent/JPS62193638A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50123815A (en) * | 1974-02-11 | 1975-09-29 | ||
JPS5348190A (en) * | 1976-10-13 | 1978-05-01 | Kobe Steel Ltd | Servo control system |
JPS56136287A (en) * | 1980-03-26 | 1981-10-24 | Nec Corp | Electron beam welding machine in air |
JPS59101416A (en) * | 1982-11-30 | 1984-06-12 | Lion Corp | Oral cavity composition |
JPS59152312A (en) * | 1983-02-18 | 1984-08-31 | Lion Corp | Oral cavity composition |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102274A (en) * | 2007-10-24 | 2009-05-14 | Kao Corp | Method for producing dentifrice granule containing non-cationic germicide |
JP2009242241A (en) * | 2007-11-21 | 2009-10-22 | Kao Corp | Dentifrice |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3560244B2 (en) | Solid drug dosage forms having a two-stage release over an extended period of time and their manufacture | |
DE3874393T2 (en) | BALL FOR CONTROLLED RELEASE OF A MEDICINAL PRODUCT. | |
CA2072933C (en) | Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients | |
DE69407404T2 (en) | SOLID PREPARATION WITH HIGH RELEASE, THEIR PRODUCTION AND USE | |
DE69914928T2 (en) | POLYMER COMPLEXES OF GLUCURONOGLUCANS | |
DE60037653T2 (en) | GELATINE-FREE SCHELL DISPERSING DOSE FORMS | |
CA2257890C (en) | Liquisolid systems and methods of preparing same | |
CA2556514C (en) | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same | |
US2484637A (en) | Powdered ointment base of methyl cellulose and sorbitol | |
DE69020541T2 (en) | GRANULATES WITH HIGH IBUPROFEN CONTENT. | |
CN1391465A (en) | Coating | |
PT92002B (en) | PROCESS FOR THE PREPARATION OF DISPENSABLE FORMULATIONS CONTAINING DICLOFENAC | |
DE10003757A1 (en) | Ibuprofen drug preparation | |
CZ300908B6 (en) | Tablet containing levothyroxine natrium and process for preparing thereof | |
JPH05320045A (en) | Spray drying method for manufacturing medicine powder composition being compressable directly to tablet | |
DE2854651A1 (en) | COATING AGENTS FOR SOLID DRUGS | |
JPS62193638A (en) | Granular agent | |
DE69733752T2 (en) | DRUGS CONTAINING OXAPROCINE SODIUM SALT, CALIUM SALT, OR TRIS (HYDROXYMETHYL) AMINOMETHANE SALT | |
CA2136607C (en) | Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer | |
US2883327A (en) | Reducing the gelation of methylcellulose by the addition of a neutral, water-soluble, amino carboxylic acid and product thereof | |
FI89455C (en) | Process for the preparation of a pharmaceutical composition | |
KR100267525B1 (en) | Cytarabine ocfosfate hard capsule | |
JPH09110663A (en) | Gel capsule blended with oil soluble component, its production and composition for oral cavity | |
JPH02704A (en) | Pharmaceutical composition improved in elution property | |
CA2054526A1 (en) | Controlled release formulations |